Page last updated: 2024-12-05

picryl chloride

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Picryl Chloride: A hapten that generates suppressor cells capable of down-regulating the efferent phase of trinitrophenol-specific contact hypersensitivity. (Arthritis Rheum 1991 Feb;34(2):180). [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

1-chloro-2,4,6-trinitrobenzene : The C-nitro compound that is chlorobenzene with three nitro substituents in the 2-, 4- and 6-positions. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

FloraRankFlora DefinitionFamilyFamily Definition
RheumgenusA plant genus of the family POLYGONACEAE. Members contain chrysophanic acid, rhein, EMODIN, and other ANTHRAQUINONES. The roots were formerly used as PURGATIVES.[MeSH]PolygonaceaeThe only family of the buckwheat order (Polygonales) of dicotyledonous flowering plants. It has 40 genera of herbs, shrubs, and trees.[MeSH]

Cross-References

ID SourceID
PubMed CID6953
CHEBI ID53053
SCHEMBL ID213849
MeSH IDM0016844

Synonyms (39)

Synonym
nsc1872
nsc-1872
benzene, 2-chloro-1,3,5-trinitro-
trinitrochlorobenzene
2-chloro-1,5-trinitrobenzene
2,6-trinitrochlorobenzene
88-88-0
picrylchloride
nsc-106297
1-chloro-2,6-trinitrobenzene
nsc106297
picryl chloride
2,6-trinitro-1-chlorobenzene
ccris 3098
2,4,6-trinitro-1-chlorobenzene
hsdb 5262
2,4,6-trinitrochlorobenzene
ai3-08846
benzene, 1-chloro-2,4,6-trinitro-
brn 1588666
1-chloro-2,4,6-trinitrobenzene
einecs 201-864-3
nsc 106297
2-chloro-1,3,5-trinitrobenzene
2-chloro-1,3,5-trinitrobenzene, >=98.0% (hplc)
tncb
CHEBI:53053 ,
inchi=1/c6h2cln3o6/c7-6-4(9(13)14)1-3(8(11)12)2-5(6)10(15)16/h1-2h
hjrjrumkqcmydl-uhfffaoysa-
AKOS003622085
z4zg7o5sz9 ,
4-05-00-00757 (beilstein handbook reference)
unii-z4zg7o5sz9
FT-0609915
EPITOPE ID:120353
picryl chloride [mi]
SCHEMBL213849
DTXSID3025910
Q2453531

Research Excerpts

Toxicity

ExcerptReferenceRelevance
"The objective of this study was to characterize the toxic effects of three well known thiol-reactive electrophilic compounds, N-ethylmaleimide (NEM), pentachlorophenol (PCP) and 1-chloro-2,4-dinitrobenzene (CDNB) on anaerobic biotransformation process."( Toxic effects of thiol-reactive compounds on anaerobic biomass.
Duran, M; Shimko, LA; Tepe, N, 2006
)
0.33

Dosage Studied

ExcerptRelevanceReference
" The augmentation was antigen specific and the same dose-response effect could be obtained with irradiated cells (2000 rad)."( Induction of contact sensitivity. Selective induction of delayed hypersensitivity by the injection of cells from draining lymph nodes into the footpads of normal recipients.
Asherson, GL; Perera, MA; Thomas, WR, 1978
)
0.26
" Ac-[D-Val13]alpha-MSH(11-13)-NH2 and Ac-[D-Lys11,D-Val13]alpha-MSH(11-13)-NH2 generally had greater anti-inflammatory activity than the parent tripeptide molecule; the dose-response relations exhibited the bell-shaped characteristics seen previously with MSH peptides."( Anti-inflammatory activity of alpha-MSH(11-13) analogs: influences of alteration in stereochemistry.
Catania, A; Hiltz, ME; Lipton, JM,
)
0.13
"A detailed dose-response curve has been established for induction of contact hypersensitivity (CH) in mice with trinitrochlorobenzene (TNCB)."( Analysis of dose response of trinitrochlorobenzene contact hypersensitivity induction in mice: pretreatment with cyclophosphamide reveals an optimal sensitizing dose.
Bergstresser, PR; Streilein, JW; Sullivan, S, 1990
)
0.28
" In mice, as well as in guinea pigs, a dose-response relationship was apparent between the sensitizing dose and both severity of response and number of animals responding."( Use of dose-response data to compare the skin sensitizing abilities of dicyclohexylmethane-4,4'-diisocyanate and picryl chloride in two animal species.
Karol, MH; Stadler, JC, 1985
)
0.48
" Narrow bands of UV (half bandwidth 3 nm) were used at 10 wavelengths from 250 to 320 nm to obtain dose-response curves."( Mechanism of immune suppression by ultraviolet irradiation in vivo. I. Evidence for the existence of a unique photoreceptor in skin and its role in photoimmunology.
De Fabo, EC; Noonan, FP, 1983
)
0.27
" In vivo administration of IL-5 to BALB/c mice increases significantly PCl-specific IgA levels to those observed in BALB/k mice and a dose-response analysis reveals that 500 units of IL-5 was the minimal effective dose, although a small increase in PCl-specific IgA levels was observed with 100 units of IL-5."( IL-5 enhances in vitro and in vivo antigen-specific IgA production in MHC genetically determined low IL-5 responder mice.
Asherson, GL; Bonanno, CT; Dieli, F; Lio, D; Salerno, A; Sireci, G, 1995
)
0.29
" Although type 1/type 2 T-cell deviation has been repeatedly demonstrated to play an important role in many human diseases and their animal models, the potential of tilting type 1/type 2 T-cell differentiation of CHS by modulating the manner of administration and dosage of hapten remains unexplored."( Epicutaneous administration of hapten through patch application augments TH2 responses which can downregulate the elicitation of murine contact hypersensitivity.
Lin, RH; Sun, CC; Wang, LF; Wu, JT, 1999
)
0.3
"In this paper, it was demonstrated that dosage of hapten has no effect on the type 1/ type 2 T-cell balance of CHS, whereas epicutaneous administration of hapten through patch application could tilt the type 1/type 2 balance to decrease type 1 and to augment type 2 T-cell responses."( Epicutaneous administration of hapten through patch application augments TH2 responses which can downregulate the elicitation of murine contact hypersensitivity.
Lin, RH; Sun, CC; Wang, LF; Wu, JT, 1999
)
0.3
" The clinical effective dosage predicted in this paper is also discussed in relation to a recently conducted Phase 2a study."( Pharmacokinetic/pharmacodynamic analyses of chymase inhibitor SUN13834 in NC/Nga mice and prediction of effective dosage for atopic dermatitis patients.
Fujieda, Y; Fukuda, Y; Maruoka, H; Muto, T; Nagahira, K; Ogata, A; Tanaka, T; Terakawa, M; Tomimori, Y; Watanabe, N, 2011
)
0.37
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (4)

RoleDescription
epitopeThe biological role played by a material entity when bound by a receptor of the adaptive immune system. Specific site on an antigen to which an antibody binds.
explosiveA substance capable of undergoing rapid and highly exothermic decomposition.
haptenAny substance capable of eliciting an immune response only when attached to a large carrier such as a protein. Examples include dinitrophenols; oligosaccharides; peptides; and heavy metals.
allergenA chemical compound, or part thereof, which causes the onset of an allergic reaction by interacting with any of the molecular pathways involved in an allergy.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
C-nitro compoundA nitro compound having the nitro group (-NO2) attached to a carbon atom.
monochlorobenzenesAny member of the class of chlorobenzenes containing a mono- or poly-substituted benzene ring in which only one substituent is chlorine.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (603)

TimeframeStudies, This Drug (%)All Drugs %
pre-1990268 (44.44)18.7374
1990's130 (21.56)18.2507
2000's126 (20.90)29.6817
2010's68 (11.28)24.3611
2020's11 (1.82)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 27.53

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index27.53 (24.57)
Research Supply Index6.44 (2.92)
Research Growth Index4.30 (4.65)
Search Engine Demand Index39.34 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (27.53)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (0.16%)5.53%
Reviews15 (2.41%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other606 (97.43%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]